Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort

被引:0
|
作者
Bahgat, Mahmoud Mohamed [1 ,2 ,7 ]
Nasraa, Mohamed Hassan [1 ,2 ]
Nadeem, Rola [1 ,2 ]
Amer, Khaled [3 ]
Hassan, Wael A. [3 ]
Elgarhy, Fadya M. [3 ]
Reda, Salem [3 ]
Fasemore, Akinyemi M. [4 ,5 ]
Foerstner, Konrad U. [5 ,6 ]
Abd-Elshafy, Dina Nadeem [1 ,2 ]
机构
[1] Natl Res Ctr, Ctr Excellence Adv Sci, Res Grp Immune and Biomarkers Infect, Cairo 12622, Egypt
[2] Natl Res Ctr, Inst Environm Res & Climate Changes, Dept Water Pollut Res, Environm Virol Lab, Giza, Egypt
[3] Egypt Ctr Res & Regenerat Med, Cairo, Egypt
[4] Univ Wurzburg, Wurzburg, Germany
[5] ZB Medinformat Ctr Life Sci, Knowledge Management, D-50931 Cologne, Germany
[6] TH Koln Univ Appl Sci, Cologne, Germany
[7] Natl Res Ctr, Pharmaceut & Drug Ind Res Inst, Dept Therapeut Chem, Giza, Egypt
关键词
COVID-19; TRANSMISSION; CORONAVIRUS; ANTIBODIES; IGG;
D O I
10.1007/s00284-023-03473-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study aimed to compare diagnostic sensitivities of a rapid test (Rt) and an ELISA kit for detecting anti-SARS-CoV-2 IgM/IgG in virus-RT-PCR-positive (VPP) and virus-RT-PCR-unchecked (VPU) subjects in an Egyptian cohort during the first wave of SARS-CoV-2 infection. The results revealed higher sensitivity of the Rt for detecting IgM/IgG in the VPP subjects. Both the Rt and ELISA showed identical sensitivities for IgM detection in the VPU subjects. The ELISA was more sensitive for detecting IgG in the VPU subjects. Generally, within both the VPP and the VPU groups, Rt was more sensitive for detecting IgM/IgG among the symptomatic (S) compared to asymptomatic (AS) subjects than ELISA. Within the VPP group, the Rt was more sensitive for detecting both IgM/IgG among the AS subjects than ELISA. In the VPU group, the Rt was more sensitive for detecting IgM among the S subjects than ELISA. The ELISA was more sensitive for detecting IgM/IgG among AS subjects than the Rt. From these results we concluded that, despite the limitation of sample size, this study indicates suitability of the used Rt for detecting anti-SARS-CoV-2 IgM/IgG among S subjects and sheds light on possibility of relying on the used ELISA for IgG detection among AS human subjects.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Development of a SERS-based lateral flow immunoassay for rapid and ultra-sensitive detection of anti-SARS-CoV-2 IgM/IgG in clinical samples
    Liu, Haifeng
    Dai, Erhei
    Xiao, Rui
    Zhou, Zihui
    Zhang, Minli
    Bai, Zikun
    Shao, Ying
    Qi, Kezong
    Tu, Jian
    Wang, Chongwen
    Wang, Shengqi
    SENSORS AND ACTUATORS B-CHEMICAL, 2021, 329
  • [32] Prothrombin changes and suggested correlation with the titers of anti-SARS-CoV-2 IgG antibodies in recently recovered from SARS-CoV-2 infection healthy volunteers
    Rachkovska, Antonina
    Strubchevska, Kateryna
    Kozyk, Marko
    Goldstein, Benjamin
    Krenytska, Daryna
    Karbovskyy, Vitalii
    Raksha, Nataliia
    Vovk, Tetiana
    Savchuk, Olexii
    Falalyeyeva, Tetyana
    Kovalchuk, Oleksandr
    Ostapchenko, Liudmyla
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2024, 36 (01): : 13 - 20
  • [33] Positive anti-SARS-CoV-2 rapid serological test results among asymptomatic blood donors
    Arabkhazaeli, Ali
    Maghsudlu, Mahtab
    Mohammadi, Saeed
    Eshghi, Peyman
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2022, 29 (01) : 24 - 30
  • [34] Anti-SARS-CoV-2 IgG ELISA: Replacing the Absorbance Plate Reader by a Regular Scanner with Open-Source Software
    Soares, Felipo D. Rojas
    Marcellos, Caio F. C.
    Nogueira, Julia N. P.
    de Abreu, Daniel P. B.
    Castilho, Leda R. R.
    de Souza junior, Mauricio B.
    Secchi, Argimiro R. R.
    PROCESSES, 2023, 11 (01)
  • [35] Rapid, label-free, and sensitive point-of-care testing of anti-SARS-CoV-2 IgM/IgG using all-fiber Fresnel reflection microfluidic biosensor
    Xu, Wenjuan
    Liu, Jiayao
    Song, Dan
    Li, Chunsheng
    Zhu, Anna
    Long, Feng
    MICROCHIMICA ACTA, 2021, 188 (08)
  • [36] Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors
    Gaviria, Anibal
    Tamayo-Trujillo, Rafael
    Paz-Cruz, Elius
    Cadena-Ullauri, Santiago
    Guevara-Ramirez, Patricia
    Ruiz-Pozo, Viviana A.
    Cevallos, Francisco
    Aguirre-Tello, Victor
    Risueno, Karla
    Yanez, Martha Paulina
    Cabrera-Andrade, Alejandro
    Zambrano, Ana Karina
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [37] Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
    Lau, C. S.
    Wong, M. S.
    Hoo, S. P.
    Heng, P. Y.
    Phua, S. K.
    Aw, T. C.
    PRACTICAL LABORATORY MEDICINE, 2021, 27
  • [38] Diagnostic performance of two commercially available coronavirus disease 2019 antibody kits: Elecsys Anti-SARS CoV-2 (Roche) and Anti-SARS-CoV-2 ELISA (IgG) (Euroimmun)
    Sarmis, Abdurrahman
    Kocoglu, Mucahide Esra
    Guclu, Hasan
    Habip, Zafer
    Ozekinci, Tuncer
    REVIEWS AND RESEARCH IN MEDICAL MICROBIOLOGY, 2023, 34 (04): : 190 - 195
  • [39] Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus
    Nuccetelli, Marzia
    Pieri, Massimo
    Gisone, Francesca
    Sarubbi, Serena
    Ciotti, Marco
    Andreoni, Massimo
    Bernardini, Sergio
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 92
  • [40] Nonlinear interdependence of the results of measuring anti-SARS-CoV-2 IgG levels using Abbott and Euroimmun test systems
    Ivanov, Andrei
    Kryshen, Evgeni
    Semenova, Elena
    JOURNAL OF CLINICAL VIROLOGY, 2023, 164